Suppr超能文献

II类限制性抗原呈递所需的一个基因定位于主要组织相容性复合体。

A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex.

作者信息

Mellins E, Kempin S, Smith L, Monji T, Pious D

机构信息

Department of Pediatrics, University of Washington 98105.

出版信息

J Exp Med. 1991 Dec 1;174(6):1607-15. doi: 10.1084/jem.174.6.1607.

Abstract

We have previously described a set of mutants (16.23-selected mutants) of a B lymphoblastoid cell line that are defective in the presentation of intact proteins to class II-restricted T cells, but effectively present immunogenic peptides. The mutations in these mutants are recessive in somatic cell hybrids and are not in Class II structural genes. Here, we report on a unique mutant, 5.2.4, in which a similar defect in class II-restricted antigen presentation has occurred in association with a one-megabase homozygous deletion in the class II region of the major histocompatibility complex (MHC). The defects in class II presentation among three of the 16.23-selected mutants, and between these mutants and 5.2.4, are noncomplementary in somatic cell hybrids. This suggests that the class II presentation-defective phenotype in all four mutants results from lesions in a single MHC-linked gene, a conclusion strengthened by the finding that in a hybrid made with a second, unrelated MHC deletion mutant, T2, the class II presentation defect in a 16.23-selected mutant is also not complemented. Mutant 5.2.4, in addition to its class II presentation defect, is also defective in surface expression of MHC class I molecules, most likely because its deletion encompasses the peptide supply factor 1 gene, whose function is known to be required for normal abundance of cell surface class I molecules. However, the surface abundance of class I molecules is normal in the 16.23-selected mutants, suggesting that the lesions affecting class I surface abundance and class II presentation result from mutations in different genes.

摘要

我们之前描述过一组B淋巴母细胞系的突变体(16.23选择的突变体),这些突变体在将完整蛋白质呈递给II类限制性T细胞方面存在缺陷,但能有效地呈递免疫原性肽段。这些突变体中的突变在体细胞杂种中是隐性的,且不在II类结构基因中。在此,我们报告一个独特的突变体5.2.4,其中在II类限制性抗原呈递方面出现了类似缺陷,同时伴有主要组织相容性复合体(MHC)II类区域一兆碱基的纯合缺失。16.23选择的突变体中有三个以及这些突变体与5.2.4之间在II类呈递方面的缺陷,在体细胞杂种中是不互补的。这表明所有四个突变体中II类呈递缺陷的表型是由单个MHC连锁基因的损伤导致的,这一结论因以下发现而得到加强:在与另一个不相关的MHC缺失突变体T2形成的杂种中,16.23选择的突变体中的II类呈递缺陷也没有得到互补。突变体5.2.4除了存在II类呈递缺陷外,其MHC I类分子的表面表达也有缺陷,很可能是因为其缺失包含了肽供应因子1基因,已知该基因的功能是细胞表面I类分子正常丰度所必需的。然而,16.23选择的突变体中I类分子的表面丰度是正常的,这表明影响I类表面丰度和II类呈递的损伤是由不同基因的突变导致的。

相似文献

引用本文的文献

2
What to do with HLA-DO/H-2O two decades later?二十年后该如何看待 HLA-DO/H-2O?
Immunogenetics. 2019 Mar;71(3):189-196. doi: 10.1007/s00251-018-01097-3. Epub 2019 Jan 26.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验